We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$61.6M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$32.2M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$21.8M
4
USO icon
United States Oil Fund
USO
+$12.8M
5
XLB icon
State Street Materials Select Sector SPDR ETF
XLB
+$11.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
2051
Axsome Therapeutics
AXSM
$11.2B
$70.2K ﹤0.01%
880
-5,646
-87% -$474K
EFXT
2052
Enerflex
EFXT
$2.62B
$70.1K ﹤0.01%
12,032
+11,159
+1,278% +$59.7K
USAC icon
2053
USA Compression Partners
USAC
$3.78B
$70K ﹤0.01%
2,624
-572
-18% -$14.6K
PPC icon
2054
Pilgrim's Pride
PPC
$6.57B
$70K ﹤0.01%
2,039
-4,968
-71% -$149K
TGNA
2055
DELISTED
TEGNA Inc
TGNA
$69.8K ﹤0.01%
4,672
-27,575
-86% -$410K
APLT
2056
DELISTED
Applied Therapeutics
APLT
$69.8K ﹤0.01%
10,261
-12,914
-56% -$58K
GDXJ icon
2057
VanEck Junior Gold Miners ETF
GDXJ
$8.33B
$69.7K ﹤0.01%
1,798
-425
-19% -$14.7K
TFIN icon
2058
Triumph Financial Inc
TFIN
$1.87B
$69.6K ﹤0.01%
877
-7,687
-90% -$581K
BBD icon
2059
Banco Bradesco
BBD
$34.3B
$69.5K ﹤0.01%
24,318
-23,692
-49% -$70.5K
ERIC icon
2060
Ericsson
ERIC
$33.6B
$69.4K ﹤0.01%
12,603
-46,936
-79% -$265K
TSHA icon
2061
Taysha Gene Therapies
TSHA
$1.92B
$69.3K ﹤0.01%
24,129
+21,258
+740% +$44.3K
FSP
2062
Franklin Street Properties
FSP
$46.4M
$69.1K ﹤0.01%
30,445
+18,112
+147% +$43.2K
PLTK icon
2063
Playtika
PLTK
$961M
$69K ﹤0.01%
9,794
-971
-9% -$7.15K
BLZE icon
2064
Backblaze
BLZE
$1.26B
$68.8K ﹤0.01%
6,721
-4,557
-40% -$42.1K
QURE icon
2065
uniQure
QURE
$3.26B
$68.5K ﹤0.01%
13,168
+10,405
+377% +$59.7K
ACB
2066
Aurora Cannabis
ACB
$235M
$68.5K ﹤0.01%
15,596
+15,240
+4,281% +$59K
MGY icon
2067
Magnolia Oil & Gas
MGY
$6.13B
$68.5K ﹤0.01%
2,638
-20,857
-89% -$458K
PRPH
2068
DELISTED
ProPhase Labs
PRPH
$68.4K ﹤0.01%
1,057
-444
-30% -$22.5K
PBH icon
2069
Prestige Consumer Healthcare
PBH
$2.43B
$68.4K ﹤0.01%
942
-13,047
-93% -$872K
TCX icon
2070
Tucows
TCX
$134M
$68.3K ﹤0.01%
3,680
+1,717
+87% +$36K
HOWL icon
2071
Werewolf Therapeutics
HOWL
$18.8M
$68.3K ﹤0.01%
+10,537
New +$61.4K
AQN icon
2072
Algonquin Power & Utilities
AQN
$4.48B
$68.3K ﹤0.01%
10,802
-19,207
-64% -$116K
RARE icon
2073
Ultragenyx Pharmaceutical
RARE
$2.6B
$68.3K ﹤0.01%
1,462
+84
+6% +$3.96K
IAG icon
2074
IAMGOLD
IAG
$10.1B
$68.1K ﹤0.01%
20,465
+18,865
+1,179% +$50.3K
CNO icon
2075
CNO Financial Group
CNO
$5.07B
$68K ﹤0.01%
2,476
-14,626
-86% -$395K
81 82
83
84 85

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.